The Expression and Role of Aquaporin 4 in Colon Cancer
Anticancer Research · 2024-02 · 44 (2) · 567-573
DOI: 10.21873/anticanres.16845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 02.02.2024. Verfasst von Atsushi Yamamoto und 12 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. Hauptthemen laut MEDLINE: Aquaporin 4, Colonic Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND/AIM: Aquaporins (AQPs) were initially discovered as water channel proteins that facilitate transcellular water movements. Recent studies have shown that AQPs are expressed and play an oncogenic role in various cancers. However, the expression and role of Aquaporin 4 (AQP4) in colon cancer have not been investigated. This study aimed to examine the clinical and pathophysiologic significance of AQP4 in colon cancer. PATIENTS AND METHODS: Immunohistochemistry (IHC) of AQP4 for 145 primary tumor samples obtained from patients with stage II or III colon cancer was performed, and the relationship between AQP4 expression and patients' prognoses was analyzed. Knockdown experiments with AQP4 small interfering RNA using human colon cancer cells were conducted to analyze the effects on cell invasiveness. RESULTS: IHC revealed that AQP4 was scarcely expressed in the noncancerous colonic mucosa. Of the 145 patients who enrolled in this study, 109 (75.2%) and 36 (24.8%) patients were classified as negative and positive for AQP4 expression, respectively. A high level of AQP4 expression is significantly associated with deeper tumors with lymph node metastasis and venous invasion. A 5-year progression-free survival rate of AQP4-positive patients was significantly worse than that of AQP-4 negative patients (70.7% vs. 87.0%, p=0.049). Furthermore, AQP4 knockdown significantly inhibited cell migration and invasion in HCT116 cells. CONCLUSION: AQP4 may be a novel biomarker and therapeutic target for colon cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
- Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan; hiro0810@koto.kpu-m.ac.jp.
- Department of Pathology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Zitieren
APA
Yamamoto, A., Shimizu, H., Takiguchi, K., Shoda, K., Shiraishi, K., Furuya, S., Akaike, H., Kawaguchi, Y., Amemiya, H., Kawaida, H., Mochizuki, K., Kondo, T., & Ichikawa, D. (2024). The Expression and Role of Aquaporin 4 in Colon Cancer. Anticancer Research, 44(2), 567-573. https://doi.org/10.21873/anticanres.16845
Vancouver
Yamamoto A, Shimizu H, Takiguchi K, Shoda K, Shiraishi K, Furuya S, et al. The Expression and Role of Aquaporin 4 in Colon Cancer. Anticancer Research. 2024;44(2):567-573. doi:10.21873/anticanres.16845
BibTeX
@article{Yamamoto2024,
author = {Yamamoto, Atsushi and Shimizu, Hiroki and Takiguchi, Koichi and Shoda, Katsutoshi and Shiraishi, Kensuke and Furuya, Shinji and Akaike, Hidenori and Kawaguchi, Yoshihiko and Amemiya, Hidetake and Kawaida, Hiromichi and Mochizuki, Kunio and Kondo, Tetsuo and Ichikawa, Daisuke},
title = {The Expression and Role of Aquaporin 4 in Colon Cancer},
journal = {Anticancer Research},
year = {2024},
volume = {44},
number = {2},
pages = {567--573},
doi = {10.21873/anticanres.16845}
}
EUVIMED